Mease, Philip J https://orcid.org/0000-0002-6620-0457
Gladman, Dafna D https://orcid.org/0000-0002-9074-0592
Deodhar, Atul
McGonagle, Dennis G
Nash, Peter
Boehncke, Wolf-Henning
Gottlieb, Alice
Xu, Xie L
Xu, Stephen
Hsia, Elizabeth C
Karyekar, Chetan S
Helliwell, Philip S https://orcid.org/0000-0002-4155-9105
Clinical trials referenced in this document:
Documents that mention this clinical trial
Old and new treatment targets in axial spondyloarthritis
https://doi.org/10.1136/rmdopen-2015-000054
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study
https://doi.org/10.1136/rmdopen-2020-001217
Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies
https://doi.org/10.1136/rmdopen-2023-003064
Funding for this research was provided by:
Janssen Research and Development